Reglan lawsuit information for people with tardive dyskinesia.
Get a free review of your possible Reglan lawsuit when you complete the form on this page.
Tardive dyskinesia (TD), a potentially irreversible and disfiguring disorder characterized by involuntary movements of the face, tongue, or extremities, can develop in patients treated with Reglan (metoclopramide). One published study reported a tardive dyskinesia prevalence of 20 percent among patients treated for at least 3 months.
The prevalence of the syndrome appears to be highest among the elderly, especially elderly women.
It is impossible to predict which patients are likely to develop the syndrome.
Both the risk of developing the syndrome and the likelihood that it will become irreversible are believed to increase with the duration of treatment and the total cumulative dose of the medication.
There is no known effective treatment for established cases of tardive dyskinesia although the syndrome may remit, partially or completely, within several weeks-to-months after metoclopramide is withdrawn.
Metoclopramide itself, however, may suppress (or partially suppress) the signs of tardive dyskinesia, thereby masking the underlying disease process.
Our Attorneys Help from Reglan attorneys | Weitz & Luxenberg law firm
Our attorneys can provide a free and confidential lawsuit review for Reglan patients who developed tardive dyskinesia (TD).
Box Warning Risks linked to the drug Reglan (Metoclopramide) | Weitz & Luxenberg
Those who developed tardive dyskinesia after taking Reglan (Metoclopramide) can get a freee review of their potential case from our lawyers.
Reglan Compensation is available for those who developed tardive dyskinesia from taking Reglan
Did Reglan cause your tardive dyskinesia? Trust Weitz & Luxenberg to get you compensation.